Puja Ghelani
Director, Healthcare and Life Sciences Strategy
Puja is a leader in the KPMG Precision Medicine practice. Her deep strategic advisory expertise ranges from M&A and growth strategy to deal diligence and execution, commercial and operating strategy, and performance transformation for precision medicine clients across the healthcare and life science ecosystem including biopharmaceuticals, diagnostics, healthcare systems, and private equity groups.
Puja’s quantitative background allows her to bring a data-driven perspective to precision medicine clients, from identifying and assessing attractive M&A opportunities across the oncologic diagnostic continuum and formulating targeted therapy launch strategies, to optimizing operational performance across R&D, commercial, and business functions. Puja has authored several thought-leadership publications on R&D performance, emerging precision medicine technologies, and the precision medicine deal landscape, and further enhances her scientific and technical knowledge through continuing education courses from Harvard Medical School. Puja has a strong interest in the productization and use of precision medicine data analytics to drive patient care, health equity, and clinical innovation.
One of Puja’s key focus areas in KPMG’s Precision Medicine group has been on developing a proprietary Precision Medicine Insights database that informs global and local strategic initiatives and shapes market development plans, product launch, and channel strategies